Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 81,478 | 66,666 | 69,037 | 49,495 | 34,863 |
| Marketable Securities | 15,373 | 12,893 | 10,328 | 18,721 | 17,682 |
| Receivables | 51,683 | 50,772 | 53,993 | 56,482 | 56,839 |
| Inventories | 85,145 | 86,194 | 83,842 | 79,510 | 77,492 |
| Income taxes - deferred | 14,135 | 14,239 | 12,855 | 13,324 | 13,785 |
| Other current assets | 5,337 | 4,812 | 5,877 | 5,753 | 5,901 |
| TOTAL | $253,151 | $235,576 | $235,932 | $223,285 | $206,562 |
| Non-Current Assets | |||||
| PPE Net | 49,437 | 49,215 | 49,029 | 48,126 | 45,529 |
| Investments And Advances | 25,934 | 21,016 | 9,511 | 2,035 | 0 |
| Intangibles | 0 | 55,208 | 0 | 0 | 0 |
| Other Non-Current Assets | 66,842 | 12,092 | 68,412 | 69,166 | 70,497 |
| TOTAL | $142,213 | $137,531 | $126,952 | $119,327 | $116,026 |
| Total Assets | $395,364 | $373,107 | $362,884 | $342,612 | $322,588 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 20,888 | 10,887 | 13,366 | 11,029 | 11,135 |
| Accrued Expenses | 38,845 | 38,890 | 39,091 | 34,090 | 33,430 |
| TOTAL | $81,102 | $71,377 | $74,017 | $66,621 | $65,443 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 12,971 | 13,220 | 13,053 | 13,007 | 12,405 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $81,102 | $71,377 | $74,017 | $66,621 | $65,443 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 135,798 | 135,776 | 134,396 | 133,526 | 131,425 |
| Common Shares | 4,157 | 4,135 | 4,101 | 4,082 | 4,036 |
| Retained earnings | 145,056 | 137,871 | 128,043 | 117,826 | 107,860 |
| Other shareholders' equity | -7,039 | -7,159 | -6,106 | -7,092 | -6,455 |
| TOTAL | $314,262 | $301,730 | $288,867 | $275,991 | $257,145 |
| Total Liabilities And Equity | $395,364 | $373,107 | $362,884 | $342,612 | $322,588 |